HCPCS Level IIdrugActive
J1559
Hizentra injection
BETOS: O1E
Effective: 2011-01-01
Referenced in 4 policies
Description
Injection, immune globulin (hizentra), 100 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hizentra
Manufacturer
CSL Behring L.L.C.
HCPCS Dosage
100 MG
Billing Units
10.0000
8
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.